Letter by Dregelid Regarding Article, “Autologous Bone-Marrow Mononuclear Cell Implantation Reduces Long-Term Major Amputation Risk in Patients With Critical Limb Ischemia: A Comparison of Atherosclerotic Peripheral Arterial Disease and Buerger Disease” | Zendy

Einar Dregelid | Zendy

Open Access

Letter by Dregelid Regarding Article, “Autologous Bone-Marrow Mononuclear Cell Implantation Reduces Long-Term Major Amputation Risk in Patients With Critical Limb Ischemia: A Comparison of Atherosclerotic Peripheral Arterial Disease and Buerger Disease”

Author(s) -

Einar Dregelid

Publication year - 2011

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.111.961375

Subject(s) - medicine , amputation , critical limb ischemia , surgery , bone marrow , ischemia , peripheral blood mononuclear cell , disease , myocardial infarction , arterial disease , vascular disease , biochemistry , chemistry , in vitro

To the Editor:A main finding in the study by Idei et al1 was that patients who underwent bone marrow mononuclear cell (BM-MNC) implantation had a highly significantly higher major amputation-free survival rate than patients who did not undergo BM-MNC implantation.A major amputation is not a spontaneous event such as stroke or myocardial infarction. Before reaching a decision concerning amputation, there is interaction between the patient and a surgeon. A surgeon nonblinded to type of treatment may have been more prone to recommend amputation in control patients …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research